| CAS ID: | 51333-22-3 |
| Molecular Formula: | C25H34O6 |
| Molecular Weight: | 430.5 g/mol |
| Monoisotopic Mass: | 430.2355 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PULMICORT FLEXHALER | ENTOCORT | S-1320 | RHINOCORT | PULMAXAN | ENTOCORT CR | BUDENOFALK | SYMBICORT | CORTIMENT | BUDELIN NOVOLIZER | RHINOCORT AQUA | PREFERID | RHINOCORT ALLERGY | ENTOCORT EC | BUDEFLAM AQUANASE | UCERIS | PULMICORT L.S. | DUORESP SPIROMAX | BUDESONIDE | AIRCORT | PULMICORT RESPULES | RHINOCORT AQUA 64 | PULMICORT |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1 | See All |
| InChI Key: | VOVIALXJUBGFJZ-KWVAZRHASA-N | |
| Smiles: | CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00746486 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Terminated |
| First Received | September 4, 2008 | Last Verified | February 8, 2017 |
| Sponsor | Dr. Falk Pharma GmbH | ||
Trial Record 2
| ClinicalTrial ID | NCT00004842 | Disease | Liver fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | February 25, 2000 | Last Verified | May 31, 2017 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | ||
Trial Record 3
| ClinicalTrial ID | NCT00587119 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | January 7, 2008 | Last Verified | October 5, 2010 |
| Sponsor | Mayo Clinic | ||
| PubChem: | 5281004 |
| ChEMBL: | CHEMBL1370 |